MULANGU, Sabue
2 entries in the GMN corpus.
2016 CE
#11375
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.
The cited paper was immediately followed in the same issue of Science by: John Misasi, Morgan A. Gilman, Masaru Kanekiyo et al, "Structural and molecular basis for Ebola virus neutralization by protective human antibo…
2019 CE
#11374
A randomized, controlled trial of Ebola virus disease therapeutics.
Order of authorship in the original publication: Mulangu, Dodd, Davey.... One synthetic drug (Remdesivir, an antiviral) and 3 biologicals were used in this trial. The 3 biologicals were: REGN-EB3, a triple monoclonal …